PlainRecalls
FDA Devices Moderate Class II Terminated

Liquid Cardiac Control, CQ5053

Reported: November 14, 2018 Initiated: October 2, 2018 #Z-0382-2019

Product Description

Liquid Cardiac Control, CQ5053

Reason for Recall

Randox has previously issued a recall for Liquid Cardiac Control CQ5053 lot 4245CK under REC334 on June 8, 2018. The firm has now confirmed the Liquid Cardiac Controls CQ5051, CQ5052 and CQ5053 are no longer suitable for the control of the Troponin T assay due to unacceptable variation between vials.

Details

Recalling Firm
Randox Laboratories Ltd.
Units Affected
2108
Distribution
Distributed to IN, NY, PR, and WV.
Location
Crumlin (North)

Frequently Asked Questions

What product was recalled?
Liquid Cardiac Control, CQ5053. Recalled by Randox Laboratories Ltd.. Units affected: 2108.
Why was this product recalled?
Randox has previously issued a recall for Liquid Cardiac Control CQ5053 lot 4245CK under REC334 on June 8, 2018. The firm has now confirmed the Liquid Cardiac Controls CQ5051, CQ5052 and CQ5053 are no longer suitable for the control of the Troponin T assay due to unacceptable variation between vials.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 14, 2018. Severity: Moderate. Recall number: Z-0382-2019.